Indication
port-wine stain
2 clinical trials
3 products
Product
HemoporfinClinical trial
Postmarketing Safety Study of Hemoporfin in Patients With Port Wine StainStatus: Completed, Estimated PCD: 2023-04-19
Clinical trial
A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Sequential Group Comparison Study to Evaluate the Safety and Efficacy of Light Dose (Fluence) in Subjects With Port-wine Birthmark of the Face and/or Neck Treated With Hemoporfin + Green Light Photodynamic TherapyStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Product
Vehicle+PDTProduct
Hemopfin+PDT